NCT05379972 2025-07-16Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric CancersUniversity of Colorado, DenverPhase 2 Active not recruiting9 enrolled
NCT06940921 2025-04-27SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal MetastasesFirst Affiliated Hospital of Chongqing Medical UniversityPhase 1/2 Active not recruiting26 enrolled